Serious bleeds in pediatric persons with hemophilia A on emicizumab prophylaxis

BACKGROUND: Clinical trials have shown success in bleed prevention with emicizumab, but real-world data on the effectiveness of emicizumab in preventing serious bleeds in the pediatric population are lacking. OBJECTIVES: To report real-world data on the effectiveness of Emicizumab in pediatric perso...

Descripción completa

Detalles Bibliográficos
Autores principales: Garcia, Jessica, Hammer, Matthew R., Zia, Ayesha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10694589/
http://dx.doi.org/10.1016/j.rpth.2023.102238

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10694589/
http://dx.doi.org/10.1016/j.rpth.2023.102238

Ejemplares similares